Company intelligence / Profile preview

Andromeda Surgical

South San Francisco, California, United Statesandromedasurgical.com ↗

Ownership: Private
Employees: ~10
Development stage: Clinical

Overview

Andromeda Surgical has developed an autonomous robotic surgery platform that recently enabled the world’s first robotic-assisted holmium laser enucleation of the prostate (HoLEP), performed in December 2024 as part of its ASTRA clinical trial. The system uses a tablet interface and AI guidance to assist surgeons, aiming to reduce learning curves and improve patient outcomes. The company plans to expand into additional urologic indications and increase levels of autonomy.

Therapeutic areas: Men's Health
Modalities: DeviceRobotic-assisted surgery platformAI-guided surgical system
Industry: Surgical Medical Devices

Partnerships

Universidad Católica, Chile [clinical site]Universidad de Chile [clinical site]

Beyond the preview

Go deeper on Andromeda Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Andromeda Surgical.

Explore the full profile